» Articles » PMID: 5637139

Impaired Urinary Concentration After Vasopressin and Its Gradual Correction in Hypothalamic Diabetes Insipidus

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1968 Mar 1
PMID 5637139
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

This study utilized rates with hereditary hypothalamic diabetes insipidus (D.I.) in order to explore possible mechanisms which prevent full urinary concentration after acute administration of vasopressin in hypothalamic D.I. and which correct this concentrating defect with prolonged therapy.IT WAS FOUND: (a) that the concentrating defect persisted even when the urinary osmolal excretion of D. I. rats was reduced to that of normal animals; (b) that the defect was not corrected more rapidly if larger doses of vasopressin were given; (c) that it persisted even when the D.I. rats were deprived of drinking water after vasopressin was given; (d) that there was osmotic equilibration between urine and renal papilla at a time when the concentrating defect was still evident; and (e) that the correction of the defect was associated with progressive and significant rise of the papillary osmolality. These studies appear to rule out osmotic diuresis, accumulation of exogenous vasopressin, persistent primary polydipsia, or delay in the induction of membrane permeability as causes for the concentrating defect. Rather, subnormal osmolality of the renal papilla, which can be corrected only gradually, accounts for the initial concentrating defect and the long time required for its correction. Reduction of water content and increase of urea content are primarily responsible for restoration of papillary osmolality to normal.

Citing Articles

Use of Urine Electrolytes and Urine Osmolality in the Clinical Diagnosis of Fluid, Electrolytes, and Acid-Base Disorders.

Kamel K, Halperin M Kidney Int Rep. 2021; 6(5):1211-1224.

PMID: 34013099 PMC: 8116912. DOI: 10.1016/j.ekir.2021.02.003.


Copeptin in the diagnosis of vasopressin-dependent disorders of fluid homeostasis.

Christ-Crain M, Fenske W Nat Rev Endocrinol. 2016; 12(3):168-76.

PMID: 26794439 DOI: 10.1038/nrendo.2015.224.


Molecular mechanisms of urea transport in health and disease.

Klein J, Blount M, Sands J Pflugers Arch. 2012; 464(6):561-72.

PMID: 23007461 PMC: 3514661. DOI: 10.1007/s00424-012-1157-0.


The physiology of urinary concentration: an update.

Sands J, Layton H Semin Nephrol. 2009; 29(3):178-95.

PMID: 19523568 PMC: 2709207. DOI: 10.1016/j.semnephrol.2009.03.008.


Reduction of exogenous vasopressin RNA poly(A) tail length increases its effectiveness in transiently correcting diabetes insipidus in the Brattleboro rat.

Jirikowski G, Sanna P, Bloom F Proc Natl Acad Sci U S A. 1993; 90(4):1435-9.

PMID: 7679506 PMC: 45888. DOI: 10.1073/pnas.90.4.1435.


References
1.
Hendrikx A, EPSTEIN F . Effect of feeding protein and urea on renal concentrating ability in the rat. Am J Physiol. 1958; 195(3):539-42. DOI: 10.1152/ajplegacy.1958.195.3.539. View

2.
Crawford J, Doyle A, PROBST J . Service of urea in renal water conservation. Am J Physiol. 1959; 196(3):545-8. DOI: 10.1152/ajplegacy.1959.196.3.545. View

3.
DIES F, Rangel S, Rivera A . Differential diagnosis between diabetes insipidus and compulsive polydipsia. Ann Intern Med. 1961; 54:710-25. DOI: 10.7326/0003-4819-54-4-710. View

4.
EPSTEIN F . Disorders of renal concentrating ability. Yale J Biol Med. 1966; 39(3):186-95. PMC: 2591220. View

5.
Jones J, Lee J . The value of rats with hereditary hypothalamic diabetes insipidus for the bioassay of vasopressin. J Endocrinol. 1967; 37(3):335-44. DOI: 10.1677/joe.0.0370335. View